pyrroles has been researched along with Triple Negative Breast Neoplasms in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 19 (61.29) | 24.3611 |
| 2020's | 12 (38.71) | 2.80 |
| Authors | Studies |
|---|---|
| Blucher, A; Chelariu-Raicu, A; Chen, TH; Coleman, RL; Creason, A; Fang, Y; Fellman, B; Feng, N; Frumovitz, M; Jazaeri, A; Kabil, N; Kim, TB; Labrie, M; Lee, S; Litton, JK; Liu, J; Lu, KH; Ma, X; Marszalek, JR; Meyer, LA; Mills, GB; Murthy, R; Schmeler, KM; Soliman, PT; Sood, AK; Sun, CC; Vellano, CP; Westin, SN; Yuan, Y | 1 |
| Danso, MA; Han, HS; Horton, J; Ma, L; Milenković, D; O'Shaughnessy, J; Pluard, TJ; Popovic, L; Richards, DA; Sorrentino, J; Tan, AR; Thummala, AR; Vasev, N; Vojnović, Ž; Wilks, ST; Wright, GS; Xiao, J | 1 |
| Chen, Y; Hin Cho, C; Imani, S; Jabbarzadeh Kaboli, P; Jomhori, M; Li, M; Luo, S; Shen, J; Wu, X; Wu, Z; Xiang, S; Xiao, Z; Zhao, Y | 1 |
| Cao, AY; Chai, WJ; Chen, CM; Chen, L; Chen, X; Di, GH; Fan, L; Guo, X; Hou, YF; Hu, X; Hu, Z; Huang, XY; Jiang, YZ; Li, JJ; Liu, GY; Ma, XY; Shao, ZM; Sun, XJ; Wang, ZH; Wu, J; Wu, SY; Xu, Y; Yang, WT; Yu, KD; Zhao, S; Zhu, XY; Zou, JJ | 1 |
| Loi, S; Salgado, R | 1 |
| Ahn, S; Cao, S; O'Shaughnessy, J; Tan, AR; Yi, JS | 1 |
| Ding, T; Shen, YH; Yang, LJ; Zhang, WD | 1 |
| Datta, KK; Dong, LF; Dutt, M; Gowda, H; Hill, M; Kalimutho, M; Kalita-de Croft, P; Khanna, KK; Lee, A; Lu, X; Neuzil, J; Pouliot, N; Raninga, PV; Sinha, D | 1 |
| Chen, C; Chen, H; Cheng, D; Jiang, X; Liu, R; Nie, Z; Wang, C; Wang, D; Wei, Z; Wu, Y; Ye, J | 1 |
| Chow, Z; Evers, BM; Johnson, J; Lee, E; Rychahou, P; Weiss, HL | 1 |
| Apostolidi, M; Gassaway, BM; Gaule, P; Muthusamy, V; Rimm, DL; Rinehart, J; Vathiotis, IA | 1 |
| Andreidesz, K; Bagone Vantus, V; Bognar, Z; Gallyas, F; Isbera, M; Kalai, T; Koszegi, B; Kovacs, D; Kovacs, K; Szabo, A; Vamos, E | 1 |
| Austin, D; Chau, B; Foos, K; Hamilton, N; Márquez-Garbán, D; Pietras, R; Sanchez, R; Vadgama, J; Wu, Y | 1 |
| Engelke, LH; Gohr, K; Hamacher, A; Kassack, MU | 1 |
| Chang, JT; Davies, P; Den Hollander, P; Gao, R; Joseph, R; Mani, SA; Miura, N; Pietila, M; Ramirez-Pena, E; Rosen, JM; Sarkar, TR; Shariati, M; Sobieski, M; Soundararajan, R; Sphyris, N; Stephan, CC; Taube, JH; Toneff, MJ; Vijay, GV; Werden, SJ; Zhao, N | 1 |
| Bahmanyar, S; Boylan, JF; Cashion, D; Condroski, K; Elsner, J; Fenalti, G; Fultz, KE; Krishna Narla, R; Kulkarni, A; LeBrun, L; Leftheris, K; Nagy, M; Pagarigan, B; Peng, X; Riggs, JR; Robinson, D; Tehrani, L; Tran, T; Zhu, D | 1 |
| Guan, X; Ji, W; Jin, J; Shi, Y; Wang, X | 1 |
| Abedini, S; Pasdar, A; Rivandi, M; Sahebkar, A; Tajbakhsh, A | 1 |
| Cataruozolo, PE; Cesari, R; Collier, M; Cortés, J; Curigliano, G; Elias, A; Goldhirsch, A; Huang, X; Kern, KA; Khosravan, R; Pivot, X | 1 |
| Baretton, GB; Bauer, T; Benad-Mehner, P; Bornhäuser, M; Ebert, R; Göbel, A; Hadji, P; Hofbauer, LC; Jakob, F; Muders, MH; Rachner, TD; Rauner, M; Schem, C; Thiele, S | 1 |
| Bonzi, MC; Craparotta, I; Gariboldi, MB; Mancini, M; Monti, E; Pagin, M; Taiana, E | 1 |
| Chen, KF; Chu, PY; Hung, MH; Kao, YP; Liu, CY; Ni, MH; Shiau, CW; Su, JC; Tai, WT; Tseng, LM; Wang, DS | 1 |
| Hyder, SM; Liang, Y; Mafuvadze, B | 1 |
| Chi, J; Dong, X; Gu, Q; Ji, R; Jia, X; Leng, X; Li, J; Liu, F; Ma, Y; Sun, B; Sun, R; Zhang, C; Zhang, D; Zhao, X | 1 |
| Jeon, M; Kim, S; Lee, J; Lee, JE; Nam, SJ | 1 |
| Hainsworth, JD; Midha, R; Peacock, NW; Priego, VM; Shastry, M; Shipley, DL; Yardley, DA | 1 |
| Ahn, KO; Choi, Y; Jeong, KC; Park, D | 1 |
| Beuselinck, B; Punie, K; Schöffski, P; Van Cleemput, J; Van Keerberghen, CA; Van Limbergen, E; Van Wambeke, S; Wildiers, H; Wolter, P | 1 |
| Li, W; Lin, Y; Liu, R; Ma, J; Shao, N; Shi, Y; Wang, S; Wu, W | 1 |
| Cheng, S; Dong, X; Gu, Q; Li, L; Lin, X; Liu, F; Liu, J; Sun, H; Sun, S; Wang, Y; Yao, N; Yao, Z; Zhang, D | 1 |
| Bello, E; Berndt, A; Camboni, G; Cavalletti, E; Colella, G; D'Incalci, M; Damia, G; Forestieri, D; Giavazzi, R; Licandro, SA; Richter, P; Taraboletti, G; Zucchetti, M | 1 |
1 review(s) available for pyrroles and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Regulators and mechanisms of anoikis in triple-negative breast cancer (TNBC): A review.
Topics: Anoikis; Berberine; Chlorobenzoates; Female; Gene Expression Regulation, Neoplastic; Humans; Pyrans; Pyrroles; Quinazolines; Saponins; Signal Transduction; Styrenes; Triple Negative Breast Neoplasms | 2019 |
5 trial(s) available for pyrroles and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Ovarian Neoplasms; Phthalazines; Piperazines; Pyrimidines; Pyrroles; Triple Negative Breast Neoplasms | 2021 |
Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Pyrimidines; Pyrroles; Triple Negative Breast Neoplasms | 2022 |
Investigating potential immune mechanisms of trilaciclib administered prior to chemotherapy in patients with metastatic triple-negative breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Humans; Pyrimidines; Pyrroles; Triple Negative Breast Neoplasms | 2023 |
Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Disease-Free Survival; Docetaxel; Fatigue; Female; Fluorouracil; Gemcitabine; Hand-Foot Syndrome; Humans; Indoles; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Pyrroles; Sunitinib; Survival Rate; Taxoids; Thrombocytopenia; Triple Negative Breast Neoplasms | 2013 |
Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Female; Humans; Indoles; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Pyrroles; Sunitinib; Treatment Outcome; Triple Negative Breast Neoplasms | 2015 |
25 other study(ies) available for pyrroles and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Berberine; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase 6; DNA (Cytosine-5-)-Methyltransferase 1; Epigenesis, Genetic; ErbB Receptors; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Lapatinib; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins p21(ras); Pyrimidines; Pyrroles; Signal Transduction; Transcriptome; Triple Negative Breast Neoplasms; Up-Regulation | 2022 |
Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial.
Topics: Albumins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Humans; Indoles; Paclitaxel; Pyrroles; Triple Negative Breast Neoplasms | 2022 |
What's in a Name? That Which We Call Immune Cells by Any Other Name Would All Smell as Sweet.
Topics: Albumins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Humans; Indoles; Paclitaxel; Pyrroles; Triple Negative Breast Neoplasms | 2022 |
Pyoluteorin induces cell cycle arrest and apoptosis in human triple-negative breast cancer cells MDA-MB-231.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Discovery; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints; Membrane Potential, Mitochondrial; Phenols; Pyrroles; Triple Negative Breast Neoplasms | 2020 |
Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Humans; Lactones; Mice; Oxidative Phosphorylation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrroles; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2020 |
Pyrrolo [3,4-
Topics: Amines; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carbolines; Cell Line, Tumor; Female; Heterocyclic Compounds; Humans; Mice; Mice, Nude; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Quinolines; Triple Negative Breast Neoplasms; X-Linked Inhibitor of Apoptosis Protein | 2020 |
Role of AMPK and Akt in triple negative breast cancer lung colonization.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Cell Line, Tumor; Energy Metabolism; Female; Heterocyclic Compounds, 3-Ring; Humans; Lung Neoplasms; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Neoplastic Cells, Circulating; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; RNA Interference; RNA, Small Interfering; Signal Transduction; Triple Negative Breast Neoplasms | 2021 |
Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes.
Topics: Active Transport, Cell Nucleus; Animals; Biomarkers, Tumor; Carrier Proteins; Cell Line, Tumor; Collagen; Cyclic N-Oxides; Drug Combinations; Genome, Human; Humans; Indolizines; Laminin; MCF-7 Cells; Membrane Proteins; Mice; Neoplasm Invasiveness; Neoplasm Transplantation; Neoplasms; Oxidation-Reduction; Phenotype; Phosphorylation; Protein Isoforms; Proteoglycans; Proteomics; Pyridazines; Pyridinium Compounds; Pyrroles; Pyruvate Kinase; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Triple Negative Breast Neoplasms | 2021 |
Cytostatic Effect of a Novel Mitochondria-Targeted Pyrroline Nitroxide in Human Breast Cancer Lines.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytostatic Agents; Female; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Membranes; Nitrogen Oxides; Pyrroles; Reactive Oxygen Species; Triple Negative Breast Neoplasms | 2021 |
Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer.
Topics: Androgen Antagonists; Androgens; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Humans; Insulin-Like Growth Factor II; Molecular Targeted Therapy; Nitriles; Phenylthiohydantoin; Pyrazoles; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Signal Transduction; Triazines; Triple Negative Breast Neoplasms | 2017 |
Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Imidazoles; Lapatinib; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; Quinazolines; Quinolines; Signal Transduction; TOR Serine-Threonine Kinases; Triple Negative Breast Neoplasms | 2017 |
GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Topics: Cell Line, Tumor; Cell Movement; Datasets as Topic; Drug Screening Assays, Antitumor; Epithelial-Mesenchymal Transition; Female; Glycogen Synthase Kinase 3 beta; Humans; Inhibitory Concentration 50; Lithium Chloride; Neoplastic Stem Cells; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Survival Analysis; Triple Negative Breast Neoplasms; Wnt Signaling Pathway | 2019 |
Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent Efficacy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Docetaxel; Drug Design; Female; Mice, SCID; Microtubule-Associated Proteins; Molecular Structure; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrimidines; Pyrroles; Rats; Structure-Activity Relationship; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2019 |
DAXX, as a Tumor Suppressor, Impacts DNA Damage Repair and Sensitizes BRCA-Proficient TNBC Cells to PARP Inhibitors.
Topics: Adaptor Proteins, Signal Transducing; Animals; Benzimidazoles; Cell Line, Tumor; Cell Movement; Cell Proliferation; Co-Repressor Proteins; DNA Damage; DNA Repair; Female; Heterografts; Humans; Mice; Molecular Chaperones; Morpholines; Nuclear Proteins; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Promoter Regions, Genetic; Pyrroles; Rad51 Recombinase; Triple Negative Breast Neoplasms; Tumor Suppressor Proteins | 2019 |
Dickkopf-1 is regulated by the mevalonate pathway in breast cancer.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Bone Density Conservation Agents; Bone Neoplasms; cdc42 GTP-Binding Protein; Cell Line, Tumor; Diphosphonates; Female; Gene Expression Regulation, Neoplastic; Heptanoic Acids; Humans; Imidazoles; Intercellular Signaling Peptides and Proteins; L Cells; Lymphocyte Activation; MCF-7 Cells; Mevalonic Acid; Mice; Osteoblasts; Osteogenesis; Osteoprotegerin; Prenylation; Pyrroles; Rho Factor; RNA Interference; RNA, Small Interfering; Triple Negative Breast Neoplasms; Wnt3A Protein; Zoledronic Acid | 2014 |
Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells.
Topics: Antibodies, Monoclonal; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; MCF-7 Cells; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Signal Transduction; Topoisomerase I Inhibitors; Topotecan; Triple Negative Breast Neoplasms | 2014 |
Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; DNA-Binding Proteins; Dose-Response Relationship, Drug; Female; Gene Expression; Humans; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Pyrroles; Regulatory Factor X Transcription Factors; Regulatory Factor X1; Signal Transduction; STAT3 Transcription Factor; Transcription Factors; Triple Negative Breast Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor.
Topics: Atorvastatin; Benzophenones; Breast Neoplasms; Cell Line, Tumor; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Gene Expression Regulation, Neoplastic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intramolecular Transferases; Pyrroles; Real-Time Polymerase Chain Reaction; Receptors, Androgen; RNA, Messenger; Transcriptional Activation; Triple Negative Breast Neoplasms | 2014 |
Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer.
Topics: AC133 Antigen; Adult; Aged; Angiogenesis Inhibitors; Animals; Antigens, CD; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Hypoxia; Indoles; MCF-7 Cells; Mice; Mice, Nude; Middle Aged; Neoplasm Transplantation; Neoplastic Cells, Circulating; Nuclear Proteins; Peptides; Pyrroles; Sunitinib; Triple Negative Breast Neoplasms; Twist-Related Protein 1 | 2014 |
Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells.
Topics: Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Movement; Enzyme-Linked Immunosorbent Assay; Epithelial-Mesenchymal Transition; Female; Fibronectins; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Invasiveness; Pyrazoles; Pyrroles; RNA, Messenger; Signal Transduction; Snail Family Transcription Factors; Transcription Factors; Transforming Growth Factor beta1; Transforming Growth Factor beta2; Triple Negative Breast Neoplasms; Vimentin; Wound Healing | 2015 |
Polypyrrole-based nanotheranostics for activatable fluorescence imaging and chemo/photothermal dual therapy of triple-negative breast cancer.
Topics: Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Hyaluronic Acid; Hyperthermia, Induced; Nanoparticles; Optical Imaging; Photochemotherapy; Phototherapy; Polymers; Pyrroles; Theranostic Nanomedicine; Triple Negative Breast Neoplasms | 2016 |
A Case of Severe Acute Cardiac Failure on Sunitinib After Left-Sided Thoracal Radiation Therapy.
Topics: Female; Heart Failure; Humans; Hypokinesia; Indoles; Middle Aged; Pyrroles; Sunitinib; Triple Negative Breast Neoplasms | 2017 |
Co-Targeting IGF-1R and Autophagy Enhances the Effects of Cell Growth Suppression and Apoptosis Induced by the IGF-1R Inhibitor NVP-AEW541 in Triple-Negative Breast Cancer Cells.
Topics: Adenine; Apoptosis; Autophagy; Autophagy-Related Protein 7; Cell Line, Tumor; Cell Proliferation; Female; G1 Phase Cell Cycle Checkpoints; Humans; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; Receptor, IGF Type 1; RNA, Small Interfering; Signal Transduction; Triple Negative Breast Neoplasms | 2017 |
Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry.
Topics: Adult; Aged; Angiogenesis Inhibitors; Animals; Antigens, CD; Breast; Cadherins; Cell Line, Tumor; Female; Fluorescent Antibody Technique; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Mice, Nude; Microcirculation; Middle Aged; Neoplasm Invasiveness; Neovascularization, Pathologic; Nuclear Proteins; Pyrroles; Sunitinib; Tissue Array Analysis; Treatment Outcome; Triple Negative Breast Neoplasms; Twist-Related Protein 1; Up-Regulation; Xenograft Model Antitumor Assays | 2017 |
The tyrosine kinase inhibitor E-3810 combined with paclitaxel inhibits the growth of advanced-stage triple-negative breast cancer xenografts.
Topics: Alanine; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Synergism; Female; Humans; Indoles; Mice; Mice, Nude; Paclitaxel; Protein Kinase Inhibitors; Pyrroles; Rabeprazole; Random Allocation; Sunitinib; Triazines; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2013 |